Connection

Brian Houston to Cyclic Nucleotide Phosphodiesterases, Type 5

Back to Details
This is a "connection" page, showing publications Brian Houston has written about Cyclic Nucleotide Phosphodiesterases, Type 5.
Brian Houston
Connection Strength
0.161
Cyclic Nucleotide Phosphodiesterases, Type 5
  1. Phosphodiesterase-5 Inhibitor Therapy and Post-Left Ventricular Assist Device Outcomes. Circ Heart Fail. 2019 06; 12(6):e006162.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.